Vifor - Striking the right balance in ANCA-associated vasculitis (AAV)

Industry room 2
Satellite Symposia
04 June 2021 17:30 - 19:00

Learning Objectives:

  • To explore the patient journey in ANCA associated vasculitis; to understand goals of therapy and the importance of balancing control of vasculitis activity with prevention of cumulative organ damage and treatment adverse events
  • To review the latest clinical trial evidence and real world data around the reality of vasculitis remission rates and the ongoing risk of relapse
  • To critically examine the clinical risks associated with high dose and prolonged low dose glucocorticoids in ANCA associated vasculitis and the importance of reducing glucocorticoid exposure while ensuring vasculitis control
  • To describe how new targeted therapy may help achieve control of vasculitis activity while avoiding glucocorticoid induced harm


Title Time Calendar .ics
04 June 2021 17:30 - 17:35 .ics
The pathogenesis of vascular lesions and the alternative complement pathway
04 June 2021 17:35 - 17:55 .ics
Glucocorticoids in ANCA associated vasculitis: Clinical efficacy and short and long term risks. Where do we stand?
04 June 2021 17:55 - 18:15 .ics
Getting the balance right? Emerging therapies in ANCA-associated vasculitis
04 June 2021 18:15 - 18:35 .ics
Q&A and Concluding remarks
04 June 2021 18:35 - 19:00 .ics